Recent advances in asymmetric organocatalytic Staudinger synthesis of β-lactams

Medicinal Chemistry

ISSN: 2161-0444

Open Access

Recent advances in asymmetric organocatalytic Staudinger synthesis of β-lactams

International Conference on Stereochemistry

August 18-19, 2016 Sao Paulo, Brazil

Plato A Magriotis

University of Patras, Greece

Posters & Accepted Abstracts: Med chem

Abstract :

In recent years, organocatalysts have dominated the field of asymmetric organic synthesis due to their ability to catalyze a variety of fundamentally important transformations. One example is the Staudinger synthesis of ?²-lactams which continue to provide unique opportunities for the design and synthesis of new derivatives with unprecedented biological profiles other than antibacterial activity. In fact, during the last two decades medicinal chemists have convincingly demonstrated that structural modifications of monocyclic ?²-lactams (monobactams) is an effective protocol for the discovery of new derivatives with novel pharmacological profiles. This lecture will cover recent progress that has been made in asymmetric organocatalytic Staudinger synthesis of ?²-lactams since the inaugural and pioneering investigations by Lectka and coworkers around the turn of the century, as well as our own efforts toward the development of a novel Gilman-Speeter process for the catalytic enantioselective synthesis of ?²-lactams.

Biography :


Google Scholar citation report
Citations: 6627

Medicinal Chemistry received 6627 citations as per Google Scholar report

Medicinal Chemistry peer review process verified at publons

Indexed In

arrow_upward arrow_upward